Medical literature search that went viral with physicians. Forbes AI 50 2026; $700M raised.
Secondary market
An indicative per-share price for OpenEvidence, averaged across a private-share marketplace. It is not a tradable quote.
Indicative Price
$562.06per share▲ 1.96%+10.78 since prior mark
As of Nov 8, 2026, averaged across 1 source
Hover to inspect recorded prices. Click to pin a point; click again to release. Drag between two points to measure the return over that span. Use arrow keys to move, shift with an arrow key to extend a span, Home or End to jump, and Escape to clear.
Source: Aggregated from multiple private-share marketplaces
Last primary round: ~$6B (2025, unverified), curated from reported financings. For information only, not investment advice.
Health
ACP licenses its guidelines to OpenEvidence for an undisclosed price
three-minute read
Health
OpenEvidence's prior-auth letters no better than ChatGPT's in Mayo test; $15 billion buys its distribution
three-minute read
Health
Doximity settles OpenEvidence's trade-secrets suit in principle as shareholders sue over 'gain share'
four-minute read